Anzeige
Mehr »
Montag, 31.08.2026 - Börsentäglich über 12.000 News
Könnte dieser Kupfer-Explorer die spannendste Nevada-Story des Herbstes werden?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
521 Leser
Artikel bewerten:
(2)

Axtria, Inc.: Axtria to Build Industry's Largest Pharma-Specific AI Engineering Team, Scaling to 1,000 by December 2026

NEW DELHI, Aug. 13, 2026 /PRNewswire/ -- Axtria Inc., a global leader in AI-first data analytics solutions for the life sciences industry, today announced plans to expand its Forward Deployed Engineering (FDE) organization to 1,000 engineers by December 2026, creating the industry's largest pharma-specific AI engineering team. The expansion represents one of Axtria's largest investments in AI talent development to date and reflects growing customer demand for engineers who can deploy, scale, and operationalize enterprise AI across commercial, medical, and market access functions.

Launched approximately 12 months ago, Axtria's Forward Deployed Engineering model was built on a simple premise: the future of AI in life sciences will be determined not by who has access to the best models, but by who can successfully deploy AI into complex enterprise environments and deliver measurable business outcomes. Today, Axtria's FDEs are embedded within leading life sciences organizations, deploying production-grade AI solutions across commercial and medical operations. Building on this momentum, Axtria is expanding the organization to 1,000 engineers by December 2026 through a combination of internal talent development and strategic hiring.

While life sciences organizations have invested heavily in modern data platforms and generative AI, many continue to face a shortage of specialized talent capable of deploying AI at enterprise scale. Technology providers often bring strong AI engineering capabilities but lack deep life sciences expertise, while in-house pharma teams understand the business but cannot always keep pace with the rapidly evolving AI ecosystem. Axtria's Forward Deployed Engineering model bridges this gap by combining both disciplines into a single engineering organization that helps clients move from AI experimentation to enterprise-scale deployment.

Axtria's Forward Deployed Engineers are trained and certified across leading AI and cloud platforms, including Anthropic, AWS, Databricks, LangChain, Microsoft, and Snowflake. Through the Axtria Institute, the company is developing life sciences domain experts into certified AI engineers who deploy solutions across Industry leading platforms and Axtria's proprietary platforms-including SalesIQ, MarketingIQ and DataMAx, helping clients modernize data foundations, improve decision-making, and scale enterprise AI with strong governance and cost efficiency.

"The industry is moving beyond AI experimentation to enterprise-wide deployment, and success now depends on execution," said Navi Chadha, CTO and Co-founder, Axtria. "Our Forward Deployed Engineers combine deep life sciences expertise with world-class AI engineering capabilities to help clients operationalize AI at scale. This expansion reflects both the demand we're seeing from customers and our commitment to building the talent needed to power the next generation of AI-enabled life sciences organizations."

"The most important investment we're making is in people," said Manish Mittal, Managing Principal and Country Head, Axtria. "Through the Axtria Institute, we're enabling our own life sciences experts to become certified AI engineers while also attracting exceptional engineering talent from the market. This creates unique career opportunities and ensures our clients have access to specialists who understand both the science of AI and the realities of life sciences.

Learn more about Axtria's Forward Deployed Engineering model or explore FDE careers.

About Axtria

Axtria helps life sciences companies harness the potential of data science and software to improve patient outcomes by connecting the right therapies to the right patients at the right time. A leading global provider of award-winning cloud software and data analytics, Axtria delivers proven solutions that help pharmaceutical, medical device, and diagnostics companies complete their journey from data to insights to action. As a participant in the United Nations Global Compact, Axtria is committed to aligning strategies and operations with universal principles on human rights, labor, environment, and anti-corruption. For more information, visit www.axtria.com.

Cision View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/axtria-to-build-industrys-largest-pharma-specific-ai-engineering-team-scaling-to-1-000-by-december-2026--302850759.html

© 2026 PR Newswire
KI braucht Strom
Halbleiter, Speicherchips und Rechenzentren haben Anlegern im KI-Boom bereits enorme Gewinne beschert. Doch jetzt zeichnet sich mit der benötigten Energie der nächste große Flaschenhals ab. Neue KI-Rechenzentren benötigen nicht mehr einige Megawatt, sondern zum Teil mehrere Gigawatt Leistung – so viel wie mehrere moderne Kernkraftwerksblöcke.

Damit beginnt ein weltweites Wettrennen um verfügbare Stromkapazitäten. Hyperscaler sichern sich bereits über langfristige Verträge gewaltige Energiemengen, während Stromnetze und Erzeugungskapazitäten mit dem Ausbau kaum Schritt halten können. Zusätzlich verschärfen geopolitische Risiken rund um den Iran-Krieg und die Straße von Hormus die Situation.

Für Energieversorger und ihre Zulieferer könnte damit ein goldenes Zeitalter beginnen. Steigende Nachfrage, langfristige Abnahmeverträge und wachsende Strompreise schaffen ein Umfeld, in dem ausgewählte Unternehmen zum nächsten großen KI-Trade werden könnten.

In unserem aktuellen Spezialreport stellen wir fünf Aktien vor, die besonders stark vom explodierenden Energiehunger der KI profitieren könnten – und bei Anlegern bislang teilweise noch unter dem Radar laufen.

Jetzt den kostenlosen Report sichern – und die nächsten Gewinner des KI-Booms entdecken!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.